Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

Caocci, Giovanni;
2021-01-01
2021
Inglese
BLOOD CANCER JOURNAL
11
1
4
4
WOS:000610150700001
2-s2.0-85098881834
33414394
Esperti anonimi
scientifica
sì
Palandri, Francesca; Palumbo, Giuseppe Alberto; Elli, Elena Maria; Polverelli, Nicola; Benevolo, Giulia; Martino, Bruno; Abruzzese, Elisabetta; Tiribe ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
36
open
Files in This Item:
File Size Format  
Ruxolitinib discontinuation syndrome, incidence, risk factors, and management in 251 pts with MF.pdf

open access

Type: versione editoriale
Size 766.74 kB
Format Adobe PDF
View/Open
766.74 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie